Wellgistics Health, a Florida-based pharmaceutical distributor, is taking a major step forward by incorporating XRP into its financial operations, placing the token at the core of a $50 million financing deal.

In a press release on Thursday, Wellgistics (WGRX) announced it had secured an equity line of credit to support its adoption of XRP-based reserves and infrastructure, allowing for real-time payments across its network.

The company aims to leverage XRP to streamline transactions within its pharmacy ecosystem, manage vendor payments, and issue credit lines secured by XRP. By using the digital asset, Wellgistics hopes to overcome common inefficiencies in the pharmaceutical industry, such as long processing times and high settlement costs.

“Integrating XRP and its infrastructure into our operations presents significant advantages for the healthcare sector,” said Wellgistics in the release.

XRP’s ability to settle transactions within 3-5 seconds—far faster than the typical 1-3 days required by ACH or wire transfers—will enable real-time payments between pharmacies, suppliers, and manufacturers. The XRP Ledger will also provide full transaction transparency, with real-time compliance tracking, rebate management, and audit capabilities. The system is expected to allow Wellgistics to process international vendor payments at much lower foreign exchange rates compared to traditional methods.

The credit facility for this integration is being provided by LDA Capital, a New York-based investment firm. However, Wellgistics did not specify when the XRP-based payment system would officially roll out across its network.